Brief: IGM Biosciences Reduces Its Workforce By 73%
09/01/2025 18:04
Jan 9 (Reuters) - IGM Biosciences Inc IGMS.O :
* IGM BIOSCIENCES PROVIDES STRATEGIC UPDATE ON AUTOIMMUNITY
PIPELINE PROGRAMS
* IGM BIOSCIENCES INC -COMPANY REDUCING ITS WORKFORCE BY 73%
* IGM BIOSCIENCES INC -COMPANY HALTING FURTHER DEVELOPMENT
OF
IMVOTAMAB (CD20 X CD3) AND IGM-2644 (CD38 X CD3)
* IGM BIOSCIENCES INC - CURRENTLY EVALUATING INTERNAL
OPTIONS AS
WELL AS POTENTIAL STRATEGIC ALTERNATIVES
Source text: ID:nGNX7zNhzv
Further company coverage: IGMS.O
Recent news on IGM Biosciences
See all newsU.S. STOCKS ON THE MOVE-Energy stocks, Apple, Vertex
U.S. STOCKS ON THE MOVE-Snap, Solventum, GlobalFoundries
IGM Biosciences rises on buyout deal with Concentra Biosciences
Brief: Igm Biosciences Enters Into Agreement To Be Acquired By Concentra Biosciences For $1.247 In Cash Per Share Plus A Contingent Value Right
IGM Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary